Session: Chemical Engineering in Cancer Therapy (2012 Annual Meeting)

Description:

To be filled in by Neil Forbes

Sponsor:

Engineering Fundamentals in Life Science

Co-Sponsor(s):

Biomedical Applications of Chemical Engineering (T7)

Chair:

Neil S. Forbes
University of Massachusetts
Chemical Engineering
159 Goessmann Hall
Amherst, MA 01003
Fax Number: 413 545-1647
Email: forbes@ecs.umass.edu

Papers:

621a

Development of Three-Dimensional Lung Multicellular Spheroids in Air and Liquid Interface Culture for the Evaluation of Anti-Cancer Therapeutics
Samantha A. Meenach, University of Kentucky; Alexandra N. Tsoras, University of Kentucky; Ronald C. McGarry, University of Kentucky; Heidi M. Mansour, University of Kentucky; J. Zach Hilt, University of Kentucky; Kimberly W. Anderson, University of Kentucky

621b

Treatment Tests of Breast Cancer in Mice Using a Vascular-Targeted Enzyme Prodrug Therapy
Brent D. Van Rite, University of Oklahoma ; Vassilios I. Sikavitsas, University of Oklahoma; Mohamad Cherry, University of Oklahoma Health Sciences Center ; Carla Kurkjian, University of Oklahoma Health Sciences Center; Roger G. Harrison, University of Oklahoma

621c

Quorum-Sensing Salmonella Selectively Trigger Protein Expression Upon Colonization within Tumors
Charles A. Swofford, University of Massachusetts; Adam T. St. Jean, University of Massachusetts; Neil S. Forbes, University of Massachusetts

621d

Inferring Tumor-Immune Interaction Networks Via Unbiased Secretome Profiling
Yogesh Kulkarni, West Virginia University; Kisheon Alexander, West Virginia University; Yueting Wu, West Virginia University; David J. Klinke, West Virginia University

621e

Design of A Biomimetic Nanostructured Tissue Engineered Bone Model for in Vitro Breast Cancer Metastasis Study
Mian Wang, George Washington University; Sidney Fu, George Washington University; Lijie Grace Zhang, The George Washington University

621f

Mechanistic Investigation of the TRAIL-Sensitization Activity of Mitoxantrone
David J. Taylor, Arizona State University; Taraka Sai Pavan Grandhi, Arizona State University; Arul Jayaraman, Texas A&M University; Kaushal Rege, Arizona State University

621g

Differential Effects of Chemokines and Growth Factors On Tumor Cell Migration Using a 3D Microfluidic in Vitro Model
Beum Jun Kim, Cornell University; Pimkhuan Hannanta-anan, Cornell University; Yoon Soo Kim, Cornell University; Michelle Chau, Cornell University; Melody A. Swartz, École Polytechnique Fédérale de Lausanne (EPFL); Mingming Wu, Cornell University

621h

Analysis of Myc-Driven Metabolic Reprogramming in B-Cells by Isotopically Nonstationary 13C Flux Analysis
Taylor A. Murphy, Vanderbilt University; Chi Dang, Abramson Cancer Center; Jamey D. Young, Vanderbilt University

See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division - See also TI: Comprehensive Quality by Design in Pharmaceutical Development and Manufacture

<< Previous Session | Next Session >>